Preoperative Radiation Therapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results From the YOUNGSTER trial
Carles Gomà(Hospital Clínic de Barcelona), Fara Brasó‐Maristany(Hospital Clínic de Barcelona), Bárbara Adamo(Hospital Clínic de Barcelona), Valeria Sirenko(Breast Cancer Research Foundation), Xavier Bargalló(Hospital Clínic de Barcelona), María Laplana(Hospital Clínic de Barcelona), Raquel Gómez Bravo(Breast Cancer Research Foundation), Oleguer Castillo(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), B. Úbeda(Hospital Clínic de Barcelona), Isaac Cebrecos(Hospital Clínic de Barcelona), María Hernández(Navarre Institute of Health Research), C. Cases(Hospital Clínic de Barcelona), Blanca González‐Farré(Hospital Clínic de Barcelona), Tomás Pascual(Breast Cancer Research Foundation), Patricia Galván(Vall d'Hebron Institute of Oncology), Paula Blasco(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Olga Martínez‐Sáez(Breast Cancer Research Foundation), Meritxell Mollà(Aptiv (United States)), Alba Llop‐Guevara(Vall d'Hebron Institut de Recerca), Isabel García-Fructuoso(Breast Cancer Research Foundation), Esther Sanfeliu(Hospital Clínic de Barcelona), Eduard Mensión(Universitat de Barcelona), Sergi Ganau(Hospital Clínic de Barcelona), A. Latorre‐Musoll(Hospital Clínic de Barcelona), Gabriela Oses(Hospital Clínic de Barcelona), Montserrat Muñoz-Mateu(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Francesco Schettini(Breast Cancer Research Foundation), María Vidal(Inserm), Aleix Prat(University of Padua), Violeta Serra(Vall d'Hebron Institute of Oncology)
International Journal of Radiation Oncology*Biology*Physics
August 5, 2025
Cited by 3
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
|Cancer Research|2017|480